Tango Therapeutics Inc. TNGX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Tango Therapeutics Inc. is a biotechnology company focused on discovering and developing precision oncology therapies. The company applies synthetic lethality and target discovery approaches to identify cancer dependencies that can be addressed with medicines designed for specific tumor types. Its current pipeline cent…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees137
TickerTNGX
Statistics
Market Cap$4.66B
Revenue (TTM)$62.4M
Net Income-$101.6M
Net Margin-162.9%
EPS$-0.87
P/E-34.26
P/S80.10
P/B12.39
EV/EBITDA-36.55
ROE-38.4%
Dividend Yield—
Price$32.29
Data: Twelve Data · Revenue = mcap / P/S